Illuminare Biotechnologies
Brooklyn, US · Founded 2016 · Delaware corporation · 1 known investors
Biotech
Founders & leadership
OC
Oliver CurmeDirector
WG
Walter GreenblattExecutive Officer, Director, Promoter
EE
Eric EdidinDirector
BL
Brian LongstreetExecutive Officer, Director
SG
Shay GrinfeldDirector, Promoter
RG
Robert GraifmanDirector, Promoter
SY
Sue YaoDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$3.6MraisedJun 2026 · 42 investors · BiotechnologyRule 506(b)
▶$3.6MraisedJun 2026 · 42 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Ezra AngristPromoter
- Oliver CurmeDirector
- Walter GreenblattExecutive Officer, Director, Promoter
- Eric EdidinDirector
- Andrew FradkinPromoter
- Brian LongstreetExecutive Officer, Director
- Shay GrinfeldDirector, Promoter
- Robert GraifmanDirector, Promoter
- Offering amount
- $4M
- Amount sold
- $3.6M
- Minimum investment
- $1.4K
- First sale
- May 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.5MofferedDec 2018 · BiotechnologyRule 506(b)
▶$2.5MofferedDec 2018 · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter GreenblattExecutive Officer
- Offering amount
- $2.5M
- Minimum investment
- $5K
- First sale
- Dec 2018
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b, 04.3
▶$2.4MraisedAug 2017 · 44 investors · BiotechnologyRule 506(b)
▶$2.4MraisedAug 2017 · 44 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert GraifmanDirector
- Shay GrinfeldExecutive Officer, Director
- Sue YaoDirector
- Offering amount
- $2.5M
- Amount sold
- $2.4M
- Minimum investment
- $5K
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2016
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
- Illuminare Biotechnologies Appoints Veteran Biopharmaceutical Leader as New CEOprnewswire.com · 2026